Company Filing History:
Years Active: 1993-1997
Title: Innovations of John W. Fenton, II
Introduction
John W. Fenton, II is a notable inventor based in Malden Bridge, NY (US). He has made significant contributions to the field of biomedical devices, particularly in the development of methods for coating invasive devices with thrombin inhibitors. With a total of three patents to his name, Fenton's work has the potential to impact therapeutic and diagnostic applications significantly.
Latest Patents
One of Fenton's latest patents is focused on methods for coating invasive devices with inhibitors of thrombin. This invention relates to novel biologically active molecules that bind to and inhibit thrombin. Specifically, these molecules are characterized by a thrombin anion-binding exosite association moiety (ABEAM), a linker portion of at least 18 .ANG. in length, and a thrombin catalytic site-directed moiety (CSDM). The invention also encompasses compositions, combinations, and methods that utilize these molecules for therapeutic, prophylactic, and diagnostic purposes.
Career Highlights
Throughout his career, John W. Fenton, II has worked with prominent companies such as Biogen, Incorporated and Health Research, Inc. His experience in these organizations has contributed to his expertise in the field of biomedical innovations.
Collaborations
Fenton has collaborated with notable individuals in the industry, including John M. Maraganore and Toni Kline. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
John W. Fenton, II is a distinguished inventor whose work in thrombin inhibitors and biomedical devices showcases his innovative spirit. His contributions are poised to advance therapeutic and diagnostic methodologies in significant ways.